Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Transpl Infect Dis. 2018 Sep 21;20(6):e12994. doi: 10.1111/tid.12994

Figure 4.

Figure 4.

Kaplan-Meier survival curves for patients who started ribavirin therapy at the URTI stage of infection (solid line), ribavirin therapy at the LRTI stage of infection (long dashed line), or no ribavirin therapy (short dashed line). There was no significant difference in survival rates between these groups (log-rank test, p=0.16).